Wells Fargo’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6
| Closed | -$6 | – | 7769 |
|
|
2024
Q1 | $6 | Sell |
6
-33
| -85% | -$57 | ﹤0.01% | 7374 |
|
|
2023
Q4 | $80 | Hold |
39
| – | – | ﹤0.01% | 6827 |
|
|
2023
Q3 | $142 | Buy |
39
+1
| +3% | +$4 | ﹤0.01% | 6670 |
|
|
2023
Q2 | $179 | Hold |
38
| – | – | ﹤0.01% | 6733 |
|
|
2023
Q1 | $178 | Buy |
+38
| New | +$214 | ﹤0.01% | 6804 |
|
|
2022
Q4 | – | Sell |
-5
| Closed | – | – | 7945 |
|
|
2022
Q3 | $0 | Sell |
5
-8
| -62% | -$280 | ﹤0.01% | 7857 |
|
|
2022
Q2 | $0 | Sell |
13
-152
| -92% | -$11.3K | ﹤0.01% | 7941 |
|
|
2022
Q1 | $24K | Sell |
165
-226
| -58% | -$33K | ﹤0.01% | 5957 |
|
|
2021
Q4 | $67K | Buy |
391
+368
| +1,600% | +$137K | ﹤0.01% | 5834 |
|
|
2021
Q3 | $12K | Sell |
23
-5
| -18% | -$2.32K | ﹤0.01% | 6154 |
|
|
2021
Q2 | $14K | Sell |
28
-24
| -46% | -$12.9K | ﹤0.01% | 6047 |
|
|
2021
Q1 | $26K | Sell |
52
-498
| -91% | -$257K | ﹤0.01% | 6081 |
|
|
2020
Q4 | $263K | Sell |
550
-333
| -38% | -$109K | ﹤0.01% | 4940 |
|
|
2020
Q3 | $254K | Buy |
883
+231
| +35% | +$57.3K | ﹤0.01% | 4823 |
|
|
2020
Q2 | $124K | Buy |
652
+590
| +952% | +$98.1K | ﹤0.01% | 5133 |
|
|
2020
Q1 | $7K | Buy |
62
+2
| +3% | +$362 | ﹤0.01% | 5824 |
|
|
2019
Q4 | $10K | Buy |
60
+5
| +9% | +$646 | ﹤0.01% | 5903 |
|
|
2019
Q3 | $8K | Sell |
55
-20
| -27% | -$2.67K | ﹤0.01% | 5993 |
|
|
2019
Q2 | $9K | Sell |
75
-220
| -75% | -$34.9K | ﹤0.01% | 5942 |
|
|
2019
Q1 | $50K | Sell |
295
-1
| -0.3% | -$171 | ﹤0.01% | 5321 |
|
|
2018
Q4 | $35K | Buy |
296
+114
| +63% | +$17.5K | ﹤0.01% | 5636 |
|
|
2018
Q3 | $27K | Buy |
182
+17
| +10% | +$7.11K | ﹤0.01% | 5759 |
|
|
2018
Q2 | $109K | Sell |
165
-1
| -0.6% | -$748 | ﹤0.01% | 5337 |
|
|
2018
Q1 | $170K | Buy |
166
+30
| +22% | +$25.1K | ﹤0.01% | 5060 |
|
|
2017
Q4 | $166K | Buy |
136
+73
| +116% | +$34.3K | ﹤0.01% | 5057 |
|
|
2017
Q3 | $12K | Buy |
63
+2
| +3% | +$317 | ﹤0.01% | 5843 |
|
|
2017
Q2 | $10K | Sell |
61
-15
| -20% | -$3.03K | ﹤0.01% | 5790 |
|
|
2017
Q1 | $19K | Hold |
76
| – | – | ﹤0.01% | 5724 |
|
|
2016
Q4 | $20K | Sell |
76
-15
| -16% | -$3.57K | ﹤0.01% | 5633 |
|
|
2016
Q3 | $19K | Sell |
91
-9
| -9% | -$2.52K | ﹤0.01% | 5614 |
|
|
2016
Q2 | $38K | Buy |
100
+10
| +11% | +$10.9K | ﹤0.01% | 5309 |
|
|
2016
Q1 | $61K | Sell |
90
-110
| -55% | -$74.1K | ﹤0.01% | 5151 |
|
|
2015
Q4 | $210K | Buy |
200
+62
| +45% | +$61.4K | ﹤0.01% | 4421 |
|
|
2015
Q3 | $119K | Buy |
138
+46
| +50% | +$38.5K | ﹤0.01% | 4771 |
|
|
2015
Q2 | $65K | Buy |
92
+46
| +100% | +$49K | ﹤0.01% | 5241 |
|
|
2015
Q1 | $103K | Sell |
46
-8
| -15% | -$13.6K | ﹤0.01% | 4730 |
|
|
2014
Q4 | $55K | Buy |
54
+38
| +238% | +$40.6K | ﹤0.01% | 4983 |
|
|
2014
Q3 | $17K | Sell |
16
-15
| -48% | -$25.3K | ﹤0.01% | 5380 |
|
|
2014
Q2 | $76K | Buy |
31
+9
| +41% | +$18.4K | ﹤0.01% | 4799 |
|
|
2014
Q1 | $41K | Buy |
22
+19
| +633% | +$44.9K | ﹤0.01% | 4988 |
|
|
2013
Q4 | $7K | Buy |
+3
| New | +$7.09K | ﹤0.01% | 5280 |
|
Other funds holding AMPE
Wells Fargo's AMPE Position: Q2 2024 in Review
Wells Fargo sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2024, closing a stake of 6 shares — an estimated $6 sold.
Wells Fargo first reported a position in AMPE in Q4 2013 and held it in 41 quarters. The position peaked at $263K in Q4 2020. 6 funds tracked by Wall St. Rank hold AMPE as of Q2 2024.
- Wells Fargo reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2024 after selling out during the quarter.
- Wells Fargo sold 6 Ampio Pharmaceuticals Inc. shares in Q2 2024, an estimated $6.
- Wells Fargo first reported a position in Ampio Pharmaceuticals Inc. in Q4 2013 and held it in 41 quarters.
- Wells Fargo's Ampio Pharmaceuticals Inc. position peaked at $263K in Q4 2020.
- 6 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2024.
Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.